Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Awarded $24M in 10x Genomics Patent Infringement Lawsuit

NEW YORK (GenomeWeb) – A jury has awarded Bio-Rad Laboratories $23.9 million in damages in the firm's patent infringement suit against 10x Genomics, the company announced yesterday.

The Federal District Court jury found that three US patents owned by the University of Chicago and exclusively licensed to Bio-Rad were willfully infringed by 10x. Specifically, the jury unanimously found that all single-cell and linked-read genomics products sold by 10x willfully infringed the patents, according to a statement from Bio-Rad.

In a separate action before the International Trade Commission, an administrative law judge made an initial determination that certain microfluidic devices used by 10x in its products infringe patent rights owned by Bio-Rad, the firm said.

Bio-Rad filed a lawsuit in 2017, claiming infringement on a separate set of seven US patents.

In a statement to GenomeWeb, a 10x spokesperson said, "We strongly disagree with the verdict. We will immediately file an appeal."

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.